Content Block Tag: NRG-RTOG 1216: High-Risk Head & Neck Cancer
‘Text/HTML’ of page ‘NRG-RTOG 1216: High-Risk Head & Neck Cancer’
Am I eligible for this study? People with high-risk head and neck cancer may be eligible for the study. Your healthcare team is the best source for information about your treatment options, including cancer clinical trials. Be sure to take this information to your doctor to discuss your questions and concerns in general and specific […]
Read More
‘Text/HTML’ of page ‘NRG-RTOG 1216: High-Risk Head & Neck Cancer’
About This Study NRG-RTOG-1216 is a clinical study that is testing two different types of drug therapy combined with radiation for people receiving treatment after their surgery for high-risk head and neck cancer. This study has two parts and the first part of the study has already been completed. The initial results showed that […]
Read More
‘Text/HTML’ of page ‘NRG-RTOG 1216: High-Risk Head & Neck Cancer’
Clinical Studies FAQ
Read More
‘Text/HTML’ of page ‘NRG-RTOG 1216: High-Risk Head & Neck Cancer’
The NRG-RTOG 12 Study FAQ
Read More